Literature DB >> 25419508

The Potential of Anti-IgE in Food Allergy Therapy.

Monali Manohar1, Kari C Nadeau1.   

Abstract

Entities:  

Keywords:  Food allergy; IgE; anaphylaxis; desensitization; omalizumab; oral food challenge; oral immunotherapy; tolerance

Year:  2014        PMID： 25419508      PMCID： PMC4235522          DOI： 10.1007/s40521-014-0015-z

Source DB:  PubMed          Journal:  Curr Treat Options Allergy


× No keyword cloud information.
  39 in total

Review 1.  The future of food allergy therapeutics.

Authors:  Michele Henson; A Wesley Burks
Journal:  Semin Immunopathol       Date:  2012-06-27       Impact factor: 9.623

2.  A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy.

Authors:  Hugh A Sampson; Donald Y M Leung; A Wesley Burks; Gideon Lack; Sami L Bahna; Stacie M Jones; Dennis A Wong
Journal:  J Allergy Clin Immunol       Date:  2011-03-11       Impact factor: 10.793

3.  Humanized anti-IgE mAb Hu-901 prevents the activation of allergen-specific T cells.

Authors:  R J van Neerven; C P van Roomen; W R Thomas; M de Boer; E F Knol; F M Davis
Journal:  Int Arch Allergy Immunol       Date:  2001 Jan-Mar       Impact factor: 2.749

4.  Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored expert panel report.

Authors:  Joshua A Boyce; Amal Assa'ad; A Wesley Burks; Stacie M Jones; Hugh A Sampson; Robert A Wood; Marshall Plaut; Susan F Cooper; Matthew J Fenton; S Hasan Arshad; Sami L Bahna; Lisa A Beck; Carol Byrd-Bredbenner; Carlos A Camargo; Lawrence Eichenfield; Glenn T Furuta; Jon M Hanifin; Carol Jones; Monica Kraft; Bruce D Levy; Phil Lieberman; Stefano Luccioli; Kathleen M McCall; Lynda C Schneider; Ronald A Simon; F Estelle R Simons; Stephen J Teach; Barbara P Yawn; Julie M Schwaninger
Journal:  Nutr Res       Date:  2011-01       Impact factor: 3.315

5.  Humanization of a mouse anti-human IgE antibody: a potential therapeutic for IgE-mediated allergies.

Authors:  F Kolbinger; J Saldanha; N Hardman; M M Bendig
Journal:  Protein Eng       Date:  1993-11

Review 6.  Effects of omalizumab on markers of inflammation in patients with allergic asthma.

Authors:  S Holgate; N Smith; M Massanari; P Jimenez
Journal:  Allergy       Date:  2009-10-15       Impact factor: 13.146

7.  Development of a two-part strategy to identify a therapeutic human bispecific antibody that inhibits IgE receptor signaling.

Authors:  Janet Jackman; Yongmei Chen; Arthur Huang; Barbara Moffat; Justin M Scheer; Steven R Leong; Wyne P Lee; Juan Zhang; Navneet Sharma; Yanmei Lu; Suhasini Iyer; Robert L Shields; Nancy Chiang; Michele C Bauer; Diana Wadley; Merone Roose-Girma; Richard Vandlen; Daniel G Yansura; Yan Wu; Lawren C Wu
Journal:  J Biol Chem       Date:  2010-05-05       Impact factor: 5.157

8.  Oral immunotherapy for food allergy: towards a new horizon.

Authors:  Evelyne Khoriaty; Dale T Umetsu
Journal:  Allergy Asthma Immunol Res       Date:  2012-11-28       Impact factor: 5.764

9.  Safety and feasibility of oral immunotherapy to multiple allergens for food allergy.

Authors:  Philippe Bégin; Lisa C Winterroth; Tina Dominguez; Shruti P Wilson; Liane Bacal; Anjuli Mehrotra; Bethany Kausch; Anthony Trela; Elisabeth Hoyte; Gerri O'Riordan; Scott Seki; Alanna Blakemore; Margie Woch; Robert G Hamilton; Kari C Nadeau
Journal:  Allergy Asthma Clin Immunol       Date:  2014-01-15       Impact factor: 3.406

10.  Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab.

Authors:  Philippe Bégin; Tina Dominguez; Shruti P Wilson; Liane Bacal; Anjuli Mehrotra; Bethany Kausch; Anthony Trela; Morvarid Tavassoli; Elisabeth Hoyte; Gerri O'Riordan; Alanna Blakemore; Scott Seki; Robert G Hamilton; Kari C Nadeau
Journal:  Allergy Asthma Clin Immunol       Date:  2014-02-20       Impact factor: 3.406
View more
  7 in total

Review 1.  Off-Label Uses of Omalizumab.

Authors:  David El-Qutob
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

Review 2.  THE JEREMIAH METZGER LECTURE NOVEL THERAPEUTIC STRATEGIES OF ALLERGIC AND IMMUNOLOGIC DISORDERS.

Authors:  Ronald G Crystal; Odelya E Pagovich
Journal:  Trans Am Clin Climatol Assoc       Date:  2018

3.  Histamine-releasing factor: a promising therapeutic target for food allergy.

Authors:  Marsha Wills-Karp
Journal:  J Clin Invest       Date:  2017-11-13       Impact factor: 19.456

Review 4.  Tree Nuts and Peanuts as a Source of Beneficial Compounds and a Threat for Allergic Consumers: Overview on Methods for Their Detection in Complex Food Products.

Authors:  Anna Luparelli; Ilario Losito; Elisabetta De Angelis; Rosa Pilolli; Francesca Lambertini; Linda Monaci
Journal:  Foods       Date:  2022-03-01

Review 5.  Improving the safety of oral immunotherapy for food allergy.

Authors:  Marta Vazquez-Ortiz; Paul J Turner
Journal:  Pediatr Allergy Immunol       Date:  2015-12-22       Impact factor: 6.377

Review 6.  Food allergen detection by mass spectrometry: the role of systems biology.

Authors:  Derek Croote; Stephen R Quake
Journal:  NPJ Syst Biol Appl       Date:  2016-09-29

7.  Haplopine Ameliorates 2,4-Dinitrochlorobenzene-Induced Atopic Dermatitis-Like Skin Lesions in Mice and TNF-α/IFN-γ-Induced Inflammation in Human Keratinocyte.

Authors:  Tae-Young Kim; Ye Jin Kim; Jonghwan Jegal; Beom-Geun Jo; Han-Seok Choi; Min Hye Yang
Journal:  Antioxidants (Basel)       Date:  2021-05-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.